Incomplete Susac Syndrome Exacerbated After Natalizumab
Neurology: Neuroimmunology and NeuroInflammation - United States
doi 10.1212/nxi.0000000000000151
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 24, 2015
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)